News

Using a technique that has shown promise in targeting cancer tumors, a Duke Health team has found a way to deploy a molecular warhead that can annihilate the bacterium that causes Lyme disease.

A specific microRNA molecule has been identified as a promising starting point for the investigation of new therapies for atherosclerosis.

Researchers at Weill Cornell Medicine have led a phase 1 trial of a new drug that delivers potent radiation therapy directly and specifically to cancer cells in patients with advanced prostate cancer.

Charged, chemically "aggressive" fragments could be the basis for synthesizing new compounds with unreactive elements that could be used for microchips and solar cells.

Researchers at Karolinska Institutet, Sweden have uncovered the molecular logic underpinning the assembly of spinal circuits that control the speed of locomotion in adult zebrafish.

Researchers have identified potential targets to treat therapy-resistant breast cancers, suggesting some already-approved drugs could be repurposed for certain cancer patients.

Aspirin has been shown to reduce colorectal cancer risk and inhibit cancer progression. A new study has revealed the molecular mechanisms behind these effects.

A new study has shown that women who are taking the oral contraceptive pill are less likely to report depression, compared to former users of the pill.

The development of two new methods to swap carbon atoms for nitrogen atoms in drug molecules – a common problem in pharmaceutical chemistry – could make it easier to develop new drugs.

Researchers have figured out how a specific metabolite controls the activity of DNA repair and how sensitive tissues are to cancer treatment.